Research
Psilocybin may improve a difficult-to-treat symptom of depression, study finds
The Brief
- New research from the University of Colorado Anschutz suggests psilocybin may help improve anhedonia, the loss of interest or ability to experience pleasure.
- The finding concerns people with treatment-resistant depression.
- In a clinical trial, researchers reported significant improvement in this symptom.
Why it matters
Anhedonia is a hard-to-treat symptom of depression, so a trial signal that psilocybin may address it could inform future research and treatment options for people with treatment-resistant depression.
Who’s affected
- clinicians and researchers in depression and psychiatry
- people with treatment-resistant depression
New research from the University of Colorado Anschutz suggests that psilocybin may help improve anhedonia, the loss of interest or ability to experience pleasure, in people with treatment-resistant depression. In a clinical trial, researchers found significant improvement in this…